Showing results (21-30 of 2,336) with videos related to
Sort By:
Pageof 234
Clinical Lung Cancer|January 29, 2011
Addition of darbepoetin alfa to dose-dense chemotherapy: results from a randomized phase II trial in small-cell lung cancer patients receiving carboplatin plus etoposideSylke Nagel, Olaf Kellner, Walburga Engel-Riedel, et al.Clinical Lung Cancer|September 15, 2010
Supersensitive mutation: two case reports of non-small-cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitorsJames S Myerson, Syed A Iqbal, Mary E R O'Brien, et al.Clinical Lung Cancer|September 15, 2010
Clinical perspectives on dose escalation for non-small-cell lung cancerAlbert J Chang, Jeffrey D BradleyClinical Lung Cancer|September 15, 2010
Low thymidylate synthase, thymidine phosphorylase, and dihydropyrimidine dehydrogenase mRNA expression correlate with prolonged survival in resected non-small-cell lung cancerPeter P Grimminger, Paul M Schneider, Ralf Metzger, et al.Clinical Lung Cancer|September 15, 2010
Comparison of 18F-Fluoroerythronitroimidazole and 18F-fluorodeoxyglucose positron emission tomography and prognostic value in locally advanced non-small-cell lung cancerLing Li, Man Hu, Hui Zhu, et al.Clinical Lung Cancer|September 15, 2010
High N-terminal pro-B-type natriuretic peptide: a biomarker of lung cancer?Nathalie Aujollet, Marjorie Meyer, Romain Cailliod, et al.Clinical Lung Cancer|July 23, 2019
Effectiveness of Treatments for Advanced Non-Small-Cell Lung Cancer With Exon 20 Insertion Epidermal Growth Factor Receptor MutationsJenn-Yu Wu, Chong-Jen Yu, Jin-Yuan ShihClinical Lung Cancer|December 25, 2013
Third-line chemotherapy in small-cell lung cancer: an international analysisDemetrios Simos, Golmehr Sajjady, Melissa Sergi, et al.Clinical Lung Cancer|December 28, 2013
Genetic mutation screen in early non--small-cell lung cancer (NSCLC) specimensJair Bar, Maya Damianovich, Goni Hout Siloni, et al.Clinical Lung Cancer|June 28, 2016
No Advantage in Survival With Targeted Therapies as Maintenance in Patients With Limited and Extensive-Stage Small Cell Lung Cancer: A Literature-Based Meta-Analysis of Randomized TrialsGiandomenico Roviello, Laura Zanotti, Maria Rosa Cappelletti, et al.Pageof 234